United Health's most recent trend suggests a bearish bias. One trading opportunity on United Health is a Bear Call Spread using a strike $352.50 short call and a strike $357.50 long call offers a potential 44.93% return on risk over the next 23 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $352.50 by expiration. The full premium credit of $1.55 would be kept by the premium seller. The risk of $3.45 would be incurred if the stock rose above the $357.50 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for United Health is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for United Health is bearish.
The RSI indicator is at 48.44 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for United Health
UnitedHealth Group Incorporated (NYSE:UNH) Annual Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Mon, 25 Jan 2021 05:35:12 +0000
The full-year results for UnitedHealth Group Incorporated ( NYSE:UNH ) were released last week, making it a good time…
Stock Market Rally Powers To Highs As Netflix, Apple Lead Big Tech Rally; Tesla Model Y Launches In China: Weekly Review
Fri, 22 Jan 2021 21:20:09 +0000
The stock market hit new highs, as Netflix surged on subscriber gains, with Apple and other big techs rallying too. Tesla Model Y deliveries began in China.
Healthcare ETFs in Focus on UnitedHealth's Solid Q4 Earnings
Thu, 21 Jan 2021 15:30:03 +0000
UnitedHealth Group (UNH) reported better-than-expected fourth-quarter 2020 results wherein it breezed past the Zacks Consensus Estimate on both earnings and revenues.
UnitedHealth 4Q Sales Top Street Estimates Driven By Optum Business
Thu, 21 Jan 2021 13:11:54 +0000
UnitedHealth Group reported better-than-expected fourth-quarter results despite a spike in pandemic-led healthcare costs. The healthcare giant’s 4Q sales rose 7.5% to $65.5 billion year-on-year, exceeding consensus estimates of $65.1 billion. Shares closed at $350.84 on Jan. 20. UnitedHealth (UNH) posted 4Q adjusted earnings of $2.52 per share, which beat analysts’ estimates of $2.40 per share. The company’s 4Q net EPS (earnings per share) of $2.30 fell from the $3.68 posted during the same quarter last year. Its adjusted EPS of $2.52 per share declined from $3.90 in 4Q19. This decline in earnings per share was largely related to higher healthcare costs due to Covid-19, the company said. For FY20, revenue rose 6% to $257.1 billion year-on-year, led by a 21% uptick in sales at its Optum business. Optum is UnitedHealth’s information technology-enabled health services business that serves different dimensions of the healthcare system including care providers, life sciences companies, and consumers. (See UNH stock analysis on TipRanks) UnitedHealth’s CEO, David S. Wichmann, commented, “We are grateful for the human spirit and resolve of our people, including our 125,000 clinicians who, with other frontline health care workers, demonstrated extraordinary collaboration, compassion and innovation.” The company affirmed its FY21 earnings outlook and expects net earnings of between $16.90 to $17.40 per share and adjusted net earnings of between $17.75 to $18.25 per share. According to UnitedHealth, this outlook includes a negative impact of approximately $1.80 per share due to Covid-19 that included testing and treatment costs and people deferring healthcare in 2020. Following the 4Q results, Oppenheimer analyst Michael Wiederhorn reiterated a Buy rating on the stock and set a price target of $375. “The company’s Optum business is a nice complement to its core managed care operations and continues to account for a large share of earnings,” Wiederhorn commented in a note to investors. Furthermore, UNH’s vertical integration strategy strengthens the company’s competitive positioning across many areas of the healthcare landscape.” Overall, analysts are bullish about the stock and the consensus is a Strong Buy with 16 analysts suggesting a Buy and 2 analysts recommending a Hold. The average price target of $396.44 implies 13% upside potential to current levels. Related News:Aclaris Explodes 220% On ‘Positive Data’ From Rheumatoid Arthritis TrialAkzo Nobel Enters Tikkurila Takeover Battle With $1.7B BidMasterCraft Is Going Digital For Its Dynamic Boat Show Season More recent articles from Smarter Analyst: 2 “Strong Buy” Penny Stocks That Could See Outsized Gains United Airlines Posts Wider-Than Feared Loss of $1.9B In 4Q; Street Says Hold Thursday’s Pre-Market: Here’s What You Need To Know Before The Market Opens Inovio Sinks 7% After Pricing Of $150.5M Share Offering; Street Says Hold
How Many UnitedHealth Group Incorporated (NYSE:UNH) Shares Do Institutions Own?
Thu, 21 Jan 2021 10:26:31 +0000
The big shareholder groups in UnitedHealth Group Incorporated ( NYSE:UNH ) have power over the company. Institutions…
Also on Market Tamer…
Follow Us on Facebook